Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added Lung Suite to their OEC 3D...
Company updates medium-term framework with progress toward financial goals; increases quarterly cash dividend by approximately 17% GE HealthCare...
Published in the Journal of Clinical Anesthesia, results from the two-phase, 250 patient pilot study show clinicians found a majority (82%) of...
New MRI technology aims to advance neuroimaging and biomarker research GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its...
Factors impacting today’s critical shortage of radiologic technologists include clinician burnout, the impact of COVID and COVID-related...
Collaboration will leverage GE HealthCare’s legacy and scale of imaging innovation and RadNet’s DeepHealth AI-powered clinical and workflow...
GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced...
GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public...
GE HealthCare (Nasdaq: GEHC) will host its Investor Day on Thursday, November 21, 2024, at Nasdaq MarketSite in New York, NY, where its...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.